Frontlight ResearchEarly access
Trial site
NHO Osaka National Hospital
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis6 trials
- Metastatic breast cancer3 trials
- Colorectal cancer2 trials
- Stroke2 trials
- Phase
- Phase 310 trials
- Phase 12 trials
- Phase 21 trial
- Status
- Completed6 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Daiichi Sankyo3 trials
- Abivax S.A.2 trials
- Eli Lilly and Company2 trials
- Joseph Broderick, MD2 trials
- Asahi Kasei Therapeutics, Inc.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Active, not recruiting
Active, not recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Active, not recruiting
Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Terminated
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026